Molecular pathological approach of uterine intravenous leiomyomatosis
- PMID: 35957719
- PMCID: PMC9358516
- DOI: 10.21037/atm-22-2804
Molecular pathological approach of uterine intravenous leiomyomatosis
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-2804/coif). The authors have no conflicts of interest to declare.
Comment on
-
Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience.Ann Transl Med. 2022 May;10(9):503. doi: 10.21037/atm-21-5376. Ann Transl Med. 2022. PMID: 35692495 Free PMC article.
References
-
- Uterine leiomyoma. Female Genital Tumours WHO Classification of Tumours, 5th ed., Vol.4. WHO Classification of Tumours Editorial Board. WORLD HEALTH ORGANIZATION. 2020; pp272-276.
-
- Intravenous leiomyotosis. Female Genital Tumours WHO Classification of Tumours, 5th ed., Vol.4. WHO Classification of Tumours Editorial Board. WORLD HEALTH ORGANIZATION. 2020; pp277-278.
Publication types
LinkOut - more resources
Full Text Sources